NuCare API

Happy Thanksgiving from all of us at NuCare!

Exciting News: The FDA categorizes bulk drug substances used in compounding into three main categories—1, 2, and 3—to guide pharmacists and healthcare providers in their safe and appropriate use. Effective September 27, 2024, the FDA has officially removed certain bulk drug substances from Category 2. For more details, please see the link below. https://lnkd.in/gGdk9Gtt #FDAUpdate #PharmacyCompounding #HealthcareCompliance #PharmaceuticalRegulations #DrugSafety #HealthcareNews #PatientSafety #CompoundingPharmacy

?? Market Intel: Understanding the Importance of Drug Master Files (DMFs) In the highly regulated pharmaceutical industry, ensuring drug quality and compliance is paramount. Drug Master Files (DMFs) serve as a cornerstone in this process. ?? DMFs are confidential documents submitted to the US FDA, containing detailed information on the ingredients, manufacturing processes, and packaging of medicines. They allow pharmaceutical manufacturers to protect proprietary data while still providing the FDA with crucial insights into drug quality and safety. ??? By overseeing these files, the FDA can ensure that drugs meet strict quality standards before reaching the market. https://lnkd.in/ghqUfFwx #Pharmaceuticals #RegulatoryAffairs #FDA #DrugMasterFiles #QualityAssurance #PharmaIndustry #PharmCompass #MarketIntel

Exciting news indeed! This decision by the FDA to allow compounding pharmacies to continue producing copies of tirzepatide is a major win for patients and healthcare providers. This is a great step forward in improving patient care and fostering pharmacy innovation. Can't wait to see how this will shape the pharmaceutical landscape in the future! ???? #FDA #Tirzepatide #Healthcare #CompoundingPharmacy #PatientCare #Pharmaceuticals

?? Breaking News: FDA Announces Compounding Pharmacies Can Continue Producing Tirzepatide Copies! ?? https://lnkd.in/gddnEqsY Exciting news for the healthcare and compounding pharmacy communities! ???? The FDA has announced that compounding pharmacies can continue producing copies of tirzepatide, a widely used medication for type 2 diabetes and obesity management. This decision is a big win for patients and healthcare providers, offering more affordable and accessible treatment options as demand for this essential drug grows. ?? A major victory for patient care and pharmacy innovation! ?? Stay tuned for updates on how this will shape the pharmaceutical landscape moving forward. ?? #FDA #Tirzepatide #Healthcare #CompoundingPharmacy #PatientCare #Pharmaceuticals

Good morning and Happy October from your NuCare API Team!

Buy Direct with NuCare Pharmaceuticals! ?? For over 20 years, NuCare Pharmaceuticals has been a trusted name in the industry, and we’re excited to announce a game-changing move in the GLP-1 market! As the unprecedented GLP-1 patient demand continues with semaglutide and tirzepatide leading the charge, we're committed to offering you top-quality products at unbeatable prices. ??? We source exclusively from FDA-registered manufacturers and rigorously third-party test all our products to ensure the highest standards. Unfortunately, we’ve noticed that some companies are buying our products and reselling them at inflated prices. ?? At NuCare, we believe in integrity and value over profits. That’s why we’re cutting our prices to beat the middleman and ensure you get the best deal possible. ???? If you're a 503a or 503b pharmacy not currently buying directly from us, we urge you to make the switch. We guarantee a minimum savings of $100 per gram compared to what you’re currently paying. Let's build a long-lasting partnership where quality and savings go hand in hand. ???? Discover the NuCare difference today and experience the value we bring to the table. Visit us at https://lnkd.in/dwq2SSfw for more details and to make the switch. #Pharmaceuticals #GLP1 #Semaglutide #Tirzepatide #Integrity #Value #NuCarePharmaceuticals #API #Pharmacy

Despite the update from Big Pharma manufacturers, the FDA has not removed Tirzepatide or Semaglutide from its shortages list. Read more here: https://lnkd.in/gMiuXR3s

The quality and stability of active pharmaceutical ingredients (APIs) are crucial for the safety and efficacy of finished products. At Nucare API, we are dedicated to delivering top-quality APIs to our clients. Explore more at nucarepharmaceuticals.com #activepharmaceuticalingredients #API #Quality #Compliance #Compounding #Outsourcingfacility